Response to Brewer

Wayne Hall; Louisa Degenhardt; Amy Gibson; Richard P. Mattick

doi:10.1080/09595230802089743/pdf

Response to Brewer

Wayne Hall
, Louisa Degenhardt
, Amy Gibson
, Richard P. Mattick

Research output: Contribution to journal › Article › peer-review

Abstract

Letter to the editor responding to the letter by Colin Brewer to the article "Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy" by Degenhardt et al.

Original language	English
Pages (from-to)	448-449
Number of pages	2
Journal	Drug and Alcohol Review
Volume	27
Issue number	4
DOIs	https://doi.org/10.1080/09595230802089743/pdf
Publication status	Published - 2008

Access to Document

10.1080/09595230802089743/pdf

Cite this

@article{3d7f9e144b2b4c93abb57c30246afdee,

title = "Response to Brewer",

abstract = "Letter to the editor responding to the letter by Colin Brewer to the article {"}Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy{"} by Degenhardt et al.",

author = "Wayne Hall and Louisa Degenhardt and Amy Gibson and Mattick, \{Richard P.\}",

year = "2008",

doi = "10.1080/09595230802089743/pdf",

language = "English",

volume = "27",

pages = "448--449",

journal = "Drug and Alcohol Review",

issn = "0959-5236",

publisher = "John Wiley and Sons Inc",

number = "4",

}

TY - JOUR

T1 - Response to Brewer

AU - Hall, Wayne

AU - Degenhardt, Louisa

AU - Gibson, Amy

AU - Mattick, Richard P.

PY - 2008

Y1 - 2008

N2 - Letter to the editor responding to the letter by Colin Brewer to the article "Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy" by Degenhardt et al.

AB - Letter to the editor responding to the letter by Colin Brewer to the article "Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy" by Degenhardt et al.

UR - http://handle.uws.edu.au:8081/1959.7/541397

U2 - 10.1080/09595230802089743/pdf

DO - 10.1080/09595230802089743/pdf

M3 - Article

SN - 0959-5236

VL - 27

SP - 448

EP - 449

JO - Drug and Alcohol Review

JF - Drug and Alcohol Review

IS - 4

ER -

Response to Brewer

Abstract

Access to Document

Other files and links

Fingerprint

Cite this